Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Mexico
  4. Mexican Stock Exchange
  5. Genomma Lab Internacional, S.A.B. de C.V.
  6. News
  7. Summary
    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.

(LAB B)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Second Quarter Ended June 30, 2020

07/22/2020 EDT

Genomma Lab Internacional, S.A.B. De C.V. Announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was MXN 3,636.325 million compared to MXN 3,277.463 million a year ago. Operating income was MXN 714,850.000000 compared to MXN 63.283 million a year ago. Net income was MXN 360.817 million compared to MXN 243.175 million a year ago. For the half year, sales was MXN 6,970.861 million compared to MXN 6,415.314 million a year ago. Operating income was MXN 135.412 million compared to MXN 1.230 million a year ago. Net income was MXN 734.451 million compared to MXN 495.436 million a year ago.


ę S&P Capital IQ 2020
All news about GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
09/07GENOMMA LAB INTERNACIONAL B DE C : Receives Good Manufacturing Practices (GMP) Certificati..
PU
08/04GENOMMA LAB INTERNACIONAL B DE C : External Auditor Ratification
PU
07/28GENOMMA LAB INTERNACIONAL B DE C : Q2 2021 Earnings Release
PU
07/28Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Second Quart..
CI
07/28TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on March 20,..
CI
07/13GENOMMA LAB INTERNACIONAL B DE C : 2Q-2021 Earnings Call Advisory
PU
04/28TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on March 20,..
CI
04/28Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the First Quarte..
CI
02/24Genomma Lab Internacional, S.A.B. De C.V. Reports Earnings Results for the Fourth Quart..
CI
02/24TRANCHE UPDATE ON GENOMMA LAB INTERN : LAB B)'s Equity Buyback Plan announced on March 20,..
CI
More news
Financials
Sales 2021 14 781 M 738 M 738 M
Net income 2021 1 645 M 82,1 M 82,1 M
Net Debt 2021 3 658 M 183 M 183 M
P/E ratio 2021 12,7x
Yield 2021 1,44%
Capitalization 19 931 M 990 M 995 M
EV / Sales 2021 1,60x
EV / Sales 2022 1,40x
Nbr of Employees 1 451
Free-Float 70,9%
Chart GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Duration : Period :
Genomma Lab Internacional, S.A.B. de C.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,77 MXN
Average target price 26,23 MXN
Spread / Average Target 32,7%
EPS Revisions
Managers and Directors
Jorge Luis Brake Valderrama Chief Executive Officer
Antonio Zamora Galland Vice President-Administration & Finance
Rodrigo Alonso Herrera Aspra Chairman
Marco Sparvieri Chief Operating Officer & Executive Vice President
Juan Alonso Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.4.94%990
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037